Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

[IL-12-induced expression of TRAIL enhances the cytotoxicity of NK cells against Jurkat cells].

Fu XY, Yang BY, Huang JQ, Long XG, Wu CY.

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2012 Sep;28(9):926-9. Chinese.

PMID:
22980654
2.

The participation of the Fas-mediated cytotoxic pathway by natural killer cells is tumor-cell-dependent.

Mori S, Jewett A, Murakami-Mori K, Cavalcanti M, Bonavida B.

Cancer Immunol Immunother. 1997 Jul;44(5):282-90.

PMID:
9247563
3.

Activated monocytes augment TRAIL-mediated cytotoxicity by human NK cells through release of IFN-γ.

Sarhan D, D'Arcy P, Wennerberg E, Lidén M, Hu J, Winqvist O, Rolny C, Lundqvist A.

Eur J Immunol. 2013 Jan;43(1):249-57. doi: 10.1002/eji.201242735. Epub 2012 Oct 26.

4.

The proteasome inhibitor bortezomib disrupts tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression and natural killer (NK) cell killing of TRAIL receptor-positive multiple myeloma cells.

Feng X, Yan J, Wang Y, Zierath JR, Nordenskjöld M, Henter JI, Fadeel B, Zheng C.

Mol Immunol. 2010 Aug;47(14):2388-96. doi: 10.1016/j.molimm.2010.05.003. Epub 2010 Jun 9.

PMID:
20542572
5.

Regulation of APO-2 ligand/trail expression in NK cells-involvement in NK cell-mediated cytotoxicity.

Johnsen AC, Haux J, Steinkjer B, Nonstad U, Egeberg K, Sundan A, Ashkenazi A, Espevik T.

Cytokine. 1999 Sep;11(9):664-72.

PMID:
10479402
6.

Expression and function of TNF-related apoptosis-inducing ligand on murine activated NK cells.

Kayagaki N, Yamaguchi N, Nakayama M, Takeda K, Akiba H, Tsutsui H, Okamura H, Nakanishi K, Okumura K, Yagita H.

J Immunol. 1999 Aug 15;163(4):1906-13.

7.
8.

Difference in cytotoxicity against hepatocellular carcinoma between liver and periphery natural killer cells in humans.

Ishiyama K, Ohdan H, Ohira M, Mitsuta H, Arihiro K, Asahara T.

Hepatology. 2006 Feb;43(2):362-72.

PMID:
16440347
10.

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) contributes to interferon gamma-dependent natural killer cell protection from tumor metastasis.

Smyth MJ, Cretney E, Takeda K, Wiltrout RH, Sedger LM, Kayagaki N, Yagita H, Okumura K.

J Exp Med. 2001 Mar 19;193(6):661-70.

11.

Interleukin-12 improves cytotoxicity of natural killer cells via upregulated expression of NKG2D.

Zhang C, Zhang J, Niu J, Zhou Z, Zhang J, Tian Z.

Hum Immunol. 2008 Aug;69(8):490-500. doi: 10.1016/j.humimm.2008.06.004. Epub 2008 Jul 9.

PMID:
18619507
12.
13.

NAB2 and EGR-1 exert opposite roles in regulating TRAIL expression in human Natural Killer cells.

Balzarolo M, Watzl C, Medema JP, Wolkers MC.

Immunol Lett. 2013 Mar;151(1-2):61-7. doi: 10.1016/j.imlet.2013.02.001. Epub 2013 Feb 14.

PMID:
23416169
14.

Membrane-bound TRAIL supplements natural killer cell cytotoxicity against neuroblastoma cells.

Sheard MA, Asgharzadeh S, Liu Y, Lin TY, Wu HW, Ji L, Groshen S, Lee DA, Seeger RC.

J Immunother. 2013 Jun;36(5):319-29. doi: 10.1097/CJI.0b013e31829b4493.

16.

Enhancement of human cord blood CD34+ cell-derived NK cell cytotoxicity by dendritic cells.

Yu Y, Hagihara M, Ando K, Gansuvd B, Matsuzawa H, Tsuchiya T, Ueda Y, Inoue H, Hotta T, Kato S.

J Immunol. 2001 Feb 1;166(3):1590-600.

17.

Regulation of Fas and Fas-ligand expression in NK cells by cytokines and the involvement of Fas-ligand in NK/LAK cell-mediated cytotoxicity.

Medvedev AE, Johnsen AC, Haux J, Steinkjer B, Egeberg K, Lynch DH, Sundan A, Espevik T.

Cytokine. 1997 Jun;9(6):394-404.

PMID:
9199873
18.

Leptin modulates dose-dependently the metabolic and cytolytic activities of NK-92 cells.

Lamas B, Goncalves-Mendes N, Nachat-Kappes R, Rossary A, Caldefie-Chezet F, Vasson MP, Farges MC.

J Cell Physiol. 2013 Jun;228(6):1202-9. doi: 10.1002/jcp.24273.

PMID:
23129404
20.

Effect of cyclosporin A on interleukin-15-activated umbilical cord blood natural killer cell function.

Lin SJ, Kuo ML.

Cytotherapy. 2008;10(4):397-405. doi: 10.1080/14653240802129885.

PMID:
18574772

Supplemental Content

Support Center